Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 77 Pancreatic Neoplasms 56 Stomach Neoplasms 52 Rectal Neoplasms 43 Esophageal Squamous Cell Carcinoma 38 Esophageal Neoplasms 38 Neoplasm Metastasis 25 Colonic Neoplasms 23 Neoplasms 15 Cholangiocarcinoma 13 Liver Neoplasms 10 Gastrointestinal Neoplasms 10 Breast Neoplasms 9 Adenocarcinoma Of Esophagus 9 Carcinoma, Hepatocellular 7 Anus Neoplasms 7 Lung Neoplasms 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Ovarian Neoplasms 5 Melanoma 5 Adenocarcinoma 5 Kidney Neoplasms 4 Gastrointestinal Diseases 4 Digestive System Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Sarcoma 3 Lymphoma 3

Interventions

Gemcitabine 15 130-nm albumin-bound paclitaxel 10 Albumin-Bound Paclitaxel 7 Oxaliplatin 5 Paclitaxel 4 Leucovorin 4 Fluorouracil 4 Carboplatin 4 Cisplatin 3 Cetuximab 3 Bevacizumab 3 pembrolizumab 2 napabucasin 2 Pemetrexed 2 PEGPH20 2 MK-4721 2 Irinotecan 2 tremelimumab 1 selinexor 1 relacorilant 1 ponatinib 1 neratinib 1 irinotecan sucrosofate 1 folfirinox 1 ensituximab 1 durvalumab 1 contrast agent BR1 1 cobimetinib 1 ceritinib 1 cc-486 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Pancreatic Ductal × Drug Therapy × Gastrointestinal × Clear all

NCT04146441 2023-01-19

PDAC

St. Olavs Hospital

Phase 2 Completed

Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡